Immune Therapeutics

(IMUN)

By |

Profile

Immune Therapeutics Inc is a specialty pharmaceutical company operating in the USA. It engages in the commercialization of patented therapies focused on the activation and re-balancing of the body's immune system. The company is involved in acquiring the patent for the development of new uses of opioid-related immune- therapies, such as low dose naltrexone (LDN) and Methionine [Met5]-enkephalin (MENK). It focuses on to improve the treatment of cancer, infections, such as human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), chronic inflammatory diseases and autoimmune diseases. The company's technology platform is built on various immunotherapies, such as Low Dose Naltrexone and Methionine-Enkephalin. It markets Low Dose Naltrexone under the IRT-103 brand.

Contact Information

Website: www.immunetherapeutics.com
Main Phone: +1 888 613-8802
Address: 37 North Orange Avenue
Address 2: Suite 607
State: FL
City / Town: Orlando
Country: USA
Postal Code: 32801

Issuer Information

Exchange: OTCQB
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0065 $ 0.0003 (4.84%)
Last Price 0.0065 Change $ 0.0003 Change % 4.84 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.00647 High 0.0069 Low 0.0061 Prev Close 0.0062
Last Trade Volume 225,100 52 Wk Hi 0.059 52 Wk Low 0.0039
Market Cap 2.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 434,322,060.00 EPS (TTM) -0.03 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.61 0.61 0.61 0.61
Low Target Price Estimate 0.61 0.61 0.61 0.61
Mean Target Price Estimate 0.61 0.61 0.61 0.61
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/17/16 02/17/16 02/17/16 02/17/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1